Literature DB >> 3394496

Haemangioblastoma. An immunohistochemical study of ten cases.

J W Grant1, P J Gallagher, C Hedinger.   

Abstract

Ten cases of cerebellar haemangioblastoma were studied using the immunoperoxidase technique for glial fibrillary acidic protein (GFAP), Factor VIII-related antigen (F8RA), Ulex europeus agglutinin 1 (UEA-1), S-100 protein, neurone-specific enolase (NSE), leucocyte common antigen, synaptophysin, chromogranin and eight polypeptide hormones (bombesin, pancreatic polypeptide, somatostatin, thyroglobulin, calcitonin, glucagon, insulin and gastrin). GFAP and S-100 were demonstrated at the periphery of all tumours and in small groups of cells in the centre of four cases. Most of these cells had the morphology of reactive astrocytes but some had the appearance of stromal cells. In general stromal cells gave negative results. F8RA and UEA-1 stained the endothelial cells in each case but there was no stromal cell reactivity. NSE was present in the stromal cell component of all tumours. There was no staining for synaptophysin, for chromogranin, or any of the polypeptide hormones. It therefore appears that some haemangioblastomas contain an admixed non-neoplastic astrocytic element. NSE, F8RA and UEA-1 staining demonstrates that the endothelial and stromal cell parts of the tumour are antigenically distinct. Recent reports of polypeptide hormone expression cannot be confirmed and it is therefore unlikely that stromal cells originate from primitive peptidergic neurones.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3394496     DOI: 10.1007/bf00687683

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  24 in total

1.  Angiomatosis retinae. An ultrastructural study and lipid analysis.

Authors:  F A Jakobiec; R L Font; F B Johnson
Journal:  Cancer       Date:  1976-11       Impact factor: 6.860

2.  Cerebellar hemangioma (hemangioblastoma); a clinicopathological review of 40 cases.

Authors:  M L SILVER; G HENNIGAR
Journal:  J Neurosurg       Date:  1952-09       Impact factor: 5.115

3.  The use of proteolytic enzymes to improve immunoglobulin staining by the PAP technique.

Authors:  B L Mepham; W Frater; B S Mitchell
Journal:  Histochem J       Date:  1979-05

4.  Ulex europaeus I lectin as a marker for tumors derived from endothelial cells.

Authors:  M Miettinen; H Holthofer; V P Lehto; A Miettinen; I Virtanen
Journal:  Am J Clin Pathol       Date:  1983-01       Impact factor: 2.493

5.  Blood group isoantigens in angioblastic meningiomas and hemangioblastomas of the central nervous system.

Authors:  K Jellinger; H Denk
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1974

6.  Factor VIII related antigen and glial fibrillary acidic protein immunoreactivity in the differential diagnosis of central nervous system hemangioblastomas.

Authors:  J I Epstein; C L White; G Mendelsohn
Journal:  Am J Clin Pathol       Date:  1984-03       Impact factor: 2.493

7.  Immunohistochemical localization of neuron-specific enolase in the human hypophysis and pituitary adenomas.

Authors:  S L Asa; N Ryan; K Kovacs; W Singer; P J Marangos
Journal:  Arch Pathol Lab Med       Date:  1984-01       Impact factor: 5.534

8.  Histogenesis of haemangioblastomas: an immunocytochemical and ultrastructural study in a case of von Hippel-Lindau syndrome.

Authors:  S M Ismail; B Jasani; G Cole
Journal:  J Clin Pathol       Date:  1985-04       Impact factor: 3.411

9.  Localization of factor VIII/von Willebrand factor and glial fibrillary acidic protein in the hemangioblastoma: implications for stromal cell histogenesis.

Authors:  R D McComb; T R Jones; S V Pizzo; D D Bigner
Journal:  Acta Neuropathol       Date:  1982       Impact factor: 17.088

10.  Glial fibrillary acidic protein in stromal cells of some capillary hemangioblastomas: significance and possible implications of an immunoperoxidase study.

Authors:  J H Deck; L J Rubinstein
Journal:  Acta Neuropathol       Date:  1981       Impact factor: 17.088

View more
  8 in total

1.  Increased expression of aquaporin 1 in human hemangioblastomas and its correlation with cyst formation.

Authors:  Yizhao Chen; Osamu Tachibana; Masashi Oda; Ruxiang Xu; Jun-Ichiro Hamada; Junkoh Yamashita; Nobuo Hashimoto; Jun A Takahashi
Journal:  J Neurooncol       Date:  2006-11-01       Impact factor: 4.130

2.  Histogenesis of stromal cells in cerebellar hemangioblastomas. An immunohistochemical study.

Authors:  I Becker; W Paulus; W Roggendorf
Journal:  Am J Pathol       Date:  1989-02       Impact factor: 4.307

3.  Histogenesis of intracranial haemangiopericytoma and haemangioblastoma. An immunohistochemical study.

Authors:  P H Theunissen; M Debets-Te Baerts; G Blaauw
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

4.  NHERF-2 maintains endothelial homeostasis.

Authors:  Resham Bhattacharya; Enfeng Wang; Shamit K Dutta; Pawan K Vohra; Guangqi E; Y S Prakash; Debabrata Mukhopadhyay
Journal:  Blood       Date:  2012-02-17       Impact factor: 22.113

5.  Novel sequences of subgroup J avian leukosis viruses associated with hemangioma in Chinese layer hens.

Authors:  Wei Pan; Yulong Gao; Fenfen Sun; Litin Qin; Zaisi Liu; Bingling Yun; Yongqiang Wang; Xiaole Qi; Honglei Gao; Xiaomei Wang
Journal:  Virol J       Date:  2011-12-21       Impact factor: 4.099

Review 6.  Systemic VHL gene functions and the VHL disease.

Authors:  Hannah L Bader; Tien Hsu
Journal:  FEBS Lett       Date:  2012-04-25       Impact factor: 4.124

7.  Reproduction of hemangioma by infection with subgroup J avian leukosis virus: the vertical transmission is more hazardous than the horizontal way.

Authors:  Yan Lin; Jing Xia; Yang Zhao; Fuyan Wang; Songcheng Yu; Nianli Zou; Xintian Wen; Sanjie Cao; Yong Huang
Journal:  Virol J       Date:  2013-03-27       Impact factor: 4.099

8.  Meningeal supratentorial hemangioblastoma in a patient with von hippel-lindau disease mimicking angioblastic menigioma.

Authors:  Hoon Kim; Ik-Seong Park; Kwang Wook Jo
Journal:  J Korean Neurosurg Soc       Date:  2013-11-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.